A vitamin D‐based strategy overcomes chemoresistance in prostate cancer - Prédicteurs moléculaires et nouvelles cibles en oncologie
Article Dans Une Revue British Journal of Pharmacology Année : 2024

A vitamin D‐based strategy overcomes chemoresistance in prostate cancer

Résumé

Background and purpose Castration‐resistant prostate cancer (CRPC) is a common male malignancy that requires new therapeutic strategies due to acquired resistance to its first‐line treatment, docetaxel. The benefits of vitamin D on prostate cancer (PCa) progression have been previously reported. This study aimed to investigate the effects of vitamin D on chemoresistance in CRPC. Experimental approach Structure function relationships of potent vitamin D analogues were determined. The combination of the most potent analogue and docetaxel was explored in chemoresistant primary PCa spheroids and in a xenograft mouse model derived from a patient with a chemoresistant CRPC. Key results Here, we show that Xe4MeCF3 is more potent than the natural ligand to induce vitamin D receptor (VDR) transcriptional activities and that it has a larger therapeutic window. Moreover, we demonstrate that VDR agonists restore docetaxel sensitivity in PCa spheroids. Importantly, Xe4MeCF3 reduces tumour growth in a chemoresistant CRPC patient‐derived xenograft. In addition, this treatment targets signalling pathways associated with cancer progression in the remaining cells. Conclusion and implications Taken together, these results unravel the potency of VDR agonists to overcome chemoresistance in CRPC and open new avenues for the clinical management of PCa.
Fichier principal
Vignette du fichier
British J Pharmacology - 2024 - Len‐Tayon - A vitamin D‐based strategy overcomes chemoresistance in prostate cancer (2).pdf (3.7 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-04687962 , version 1 (04-09-2024)

Licence

Identifiants

Citer

Kateryna Len‐tayon, Claire Beraud, Clara Fauveau, Anna Y Belorusova, Yassmine Chebaro, et al.. A vitamin D‐based strategy overcomes chemoresistance in prostate cancer. British Journal of Pharmacology, 2024, Online ahead of print. ⟨10.1111/bph.16492⟩. ⟨hal-04687962⟩
0 Consultations
0 Téléchargements

Altmetric

Partager

More